البحث عن طبيب

John Joerns, M.D.

  1. Critical Care Specialist
  2. Internist
  3. Transplant Pulmonologist

المنشورات

  1. Joerns J., White B.A., Pennington K., Razonable R.R., Saddoughi S.. Scedosporium Empyema After Bilateral Lung Re-Transplant The Journal of Heart and Lung Transplantation. 2025; 44(4):S308.
  2. Joerns J., White B.A., Pennington K., Razonable R.R., Saddoughi S.. Scedosporium Empyema After Bilateral Lung Re-Transplant The Journal of Heart and Lung Transplantation. 2025; 44(4):S308.
  3. Torres F, Shedd C, Kaza V, Bollineni S, Banga A, Mohanka MR, Ladikos N, Wijesinha M, Mahan LD, Lawrence A, Joerns J, Terada L, Timofte I. Outpatient management of Post-COVID syndrome - single center experience. Heart Lung. 2024 May 16; 67:137-143 [Epub ahead of print]
    View PubMed
  4. Torres F, Shedd C, Kaza V, Bollineni S, Banga A, Mohanka MR, Ladikos N, Wijesinha M, Mahan LD, Lawrence A, Joerns J, Terada L, Timofte I. Outpatient management of Post-COVID syndrome - single center experience. Heart Lung. 2024 May 16; 67:137-143 [Epub ahead of print]
    View PubMed
  5. Narasimhan M, Muthukumar A, Sataranatarajan K, Mahimainathan L, Mahan L, Timofte I, Bollineni S, Joerns J, Zhang S, Gorman A, Banga A, Mohanka M, Torres F, Lawrence A, Thalachallour M, Kaza V. Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients. Viruses. 2023 Oct 3; 15 (10) Epub 2023 Oct 03
    View PubMed
  6. Narasimhan M, Muthukumar A, Sataranatarajan K, Mahimainathan L, Mahan L, Timofte I, Bollineni S, Joerns J, Zhang S, Gorman A, Banga A, Mohanka M, Torres F, Lawrence A, Thalachallour M, Kaza V. Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients. Viruses. 2023 Oct 3; 15 (10) Epub 2023 Oct 03
    View PubMed
  7. Brandon W, Dunn C, Bollineni S, Joerns J, Lawrence A, Mohanka M, Timofte I, Torres F, Kaza V. Management of donor-specific antibodies in lung transplantation. Front Transplant. 2023; 2:1248284 Epub 2023 Sept 29
    View PubMed
  8. Brandon W, Dunn C, Bollineni S, Joerns J, Lawrence A, Mohanka M, Timofte I, Torres F, Kaza V. Management of donor-specific antibodies in lung transplantation. Front Transplant. 2023; 2:1248284 Epub 2023 Sept 29
    View PubMed
  9. Mahan LD, Mohanka MR, Joerns J, Lawrence A, Bollineni S, Kaza V, Timofte I, La Hoz RM, Sorelle J, Terada LS, Kershaw CD, Torres F, Banga A. A Case Report of Breakthrough Infections With 2 SARS-CoV-2 Variants in a Lung Transplant Patient. Transplant Proc. 2022 Dec; 54(10):2698-2701. Epub 2022 Jul 26.
    View PubMed
  10. Mahan LD, Mohanka MR, Joerns J, Lawrence A, Bollineni S, Kaza V, Timofte I, La Hoz RM, Sorelle J, Terada LS, Kershaw CD, Torres F, Banga A. A Case Report of Breakthrough Infections With 2 SARS-CoV-2 Variants in a Lung Transplant Patient. Transplant Proc. 2022 Dec; 54(10):2698-2701. Epub 2022 Jul 26.
    View PubMed
  11. Bollineni S, Mahan LD, Lawrence A, Joerns J, Timofte I, Torres F, Kaza V, La Hoz RM, SoRelle JA, Kershaw CD, Terada LS, Zhang S, Mohanka MR, Banga A. COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections. Transplant Proc. 2022 Jul-Aug; 54 (6):1517-1523 Epub 2022 June 15
    View PubMed
  12. Lawrence A, Lovin D, Mohanka MR, Joerns J, Bollineni S, Kaza V, Torres F, Murala J, Peltz M, Wait MA, Banga A. Diaphragmatic plication among lung transplant patients: A single-center experience. Clin Transplant. 2022 Jul; 36 (7):e14683 Epub 2022 May 03
    View PubMed
  13. Bollineni S, Mahan LD, Lawrence A, Joerns J, Timofte I, Torres F, Kaza V, La Hoz RM, SoRelle JA, Kershaw CD, Terada LS, Zhang S, Mohanka MR, Banga A. COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections. Transplant Proc. 2022 Jul-Aug; 54 (6):1517-1523 Epub 2022 June 15
    View PubMed
  14. Lawrence A, Lovin D, Mohanka MR, Joerns J, Bollineni S, Kaza V, Torres F, Murala J, Peltz M, Wait MA, Banga A. Diaphragmatic plication among lung transplant patients: A single-center experience. Clin Transplant. 2022 Jul; 36 (7):e14683 Epub 2022 May 03
    View PubMed
  15. Joerns J, Bollineni S, Mahan LD, Mohanka MR, Lawrence A, Timofte I, Torres F, La Hoz RM, Zhang S, Kershaw CD, Kaza V, Terada LS, Banga A. High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant Patients. Transplantation 2022 May 1; 106 (5):e271-e274 Epub 2022 Mar 01
    View PubMed
  16. Joerns J, Bollineni S, Mahan LD, Mohanka MR, Lawrence A, Timofte I, Torres F, La Hoz RM, Zhang S, Kershaw CD, Kaza V, Terada LS, Banga A. High-dose Mycophenolate Use at Vaccination Is Independently Associated With Breakthrough COVID-19 Among Lung Transplant Patients. Transplantation 2022 May 1; 106 (5):e271-e274 Epub 2022 Mar 01
    View PubMed
  17. Mohanka MR, Joerns J, Lawrence A, Bollineni S, Kaza V, Cheruku S, Leveno M, Chen C, Terada LS, Kershaw CD, Torres F, Peltz M, Wait MA, Hackmann AE, Banga A. ECMO Long Haulers: A Distinct Phenotype of COVID-19-Associated ARDS With Implications for Lung Transplant Candidacy. Transplantation. 2022 Apr 1; 106 (4):e202-e211
    View PubMed
  18. Bollineni S, Mahan LD, Duncan P, Mohanka MR, Lawrence A, Joerns J, Timofte I, Torres F, La Hoz RM, Kershaw CD, Terada LS, Kaza V, Banga A. Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID-19. Transpl Infect Dis. 2022 Apr; 24 (2):e13784 Epub 2022 Jan 19
    View PubMed
  19. Bollineni S, Mahan LD, Duncan P, Mohanka MR, Lawrence A, Joerns J, Timofte I, Torres F, La Hoz RM, Kershaw CD, Terada LS, Kaza V, Banga A. Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID-19. Transpl Infect Dis. 2022 Apr; 24 (2):e13784 Epub 2022 Jan 19
    View PubMed
  20. Mohanka MR, Joerns J, Lawrence A, Bollineni S, Kaza V, Cheruku S, Leveno M, Chen C, Terada LS, Kershaw CD, Torres F, Peltz M, Wait MA, Hackmann AE, Banga A. ECMO Long Haulers: A Distinct Phenotype of COVID-19-Associated ARDS With Implications for Lung Transplant Candidacy. Transplantation. 2022 Apr 1; 106 (4):e202-e211
    View PubMed
  21. Harris ZM, Sun Y, Joerns J, Clark B, Hu B, Korde A, Sharma L, Shin HJ, Manning EP, Placek L, Unutmaz D, Stanley G, Chun H, Sauler M, Rajagopalan G, Zhang X, Kang MJ, Koff JL. Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury. Oxid Med Cell Longev. 2022; 2022:9518592 Epub 2022 Sept 20
    View PubMed
  22. Harris ZM, Sun Y, Joerns J, Clark B, Hu B, Korde A, Sharma L, Shin HJ, Manning EP, Placek L, Unutmaz D, Stanley G, Chun H, Sauler M, Rajagopalan G, Zhang X, Kang MJ, Koff JL. Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia-Induced Lung Injury. Oxid Med Cell Longev. 2022; 2022:9518592 Epub 2022 Sept 20
    View PubMed
  23. Mahan LD, Lill I, Halverson Q, Mohanka MR, Lawrence A, Joerns J, Bollineni S, Kaza V, La Hoz RM, Zhang S, Kershaw CD, Terada LS, Torres F, Banga A. Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation. Transpl Infect Dis. 2021 Dec; 23 (6):e13739 Epub 2021 Oct 17
    View PubMed
  24. Mahan LD, Lill I, Halverson Q, Mohanka MR, Lawrence A, Joerns J, Bollineni S, Kaza V, La Hoz RM, Zhang S, Kershaw CD, Terada LS, Torres F, Banga A. Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation. Transpl Infect Dis. 2021 Dec; 23 (6):e13739 Epub 2021 Oct 17
    View PubMed
  25. Mohanka MR, Mahan LD, Joerns J, Lawrence A, Bollineni S, Kaza V, La Hoz RM, Kershaw CD, Terada LS, Torres F, Banga A. Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19. J Heart Lung Transplant. 2021 Sep; 40 (9):936-947 Epub 2021 May 18
    View PubMed
  26. Mohanka MR, Mahan LD, Joerns J, Lawrence A, Bollineni S, Kaza V, La Hoz RM, Kershaw CD, Terada LS, Torres F, Banga A. Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19. J Heart Lung Transplant. 2021 Sep; 40 (9):936-947 Epub 2021 May 18
    View PubMed
  27. Mahan LD, Points A, Mohanka MR, Bollineni S, Joerns J, Kaza V, La Hoz RM, Gao A, Zhang S, Torres F, Banga A. Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection. Transpl Infect Dis. 2021 Aug; 23 (4):e13661 Epub 2021 June 22
    View PubMed
  28. Mahan LD, Points A, Mohanka MR, Bollineni S, Joerns J, Kaza V, La Hoz RM, Gao A, Zhang S, Torres F, Banga A. Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection. Transpl Infect Dis. 2021 Aug; 23 (4):e13661 Epub 2021 June 22
    View PubMed
  29. Mohanka M, Pinho DF, Garcia H, Kanade R, Bollineni S, Joerns J, Kaza V, Mathews D, Torres F, Zhang S, Banga A. Spectrum of findings on ventilation‒perfusion lung scintigraphy after lung transplantation and association with outcomes. J Heart Lung Transplant. 2021 May; 40 (5):377-386 Epub 2021 Jan 16
    View PubMed
  30. Mohanka M, Pinho DF, Garcia H, Kanade R, Bollineni S, Joerns J, Kaza V, Mathews D, Torres F, Zhang S, Banga A. Spectrum of findings on ventilation‒perfusion lung scintigraphy after lung transplantation and association with outcomes. J Heart Lung Transplant. 2021 May; 40 (5):377-386 Epub 2021 Jan 16
    View PubMed
  31. Kaza V, Zhu C, Terada LS, Wang L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Li QZ. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction. Hum Immunol. 2021 Jan; 82 (1):25-35 Epub 2020 Oct 28
    View PubMed
  32. Mahan LD, Kanade R, Mohanka MR, Bollineni S, Joerns J, Kaza V, Torres F, La Hoz RM, Banga A. Characteristics and outcomes among patients with community-acquired respiratory virus infections during the first year after lung transplantation. Clin Transplant. 2021 Jan; 35 (1):e14140 Epub 2020 Nov 20
    View PubMed
  33. Kaza V, Zhu C, Terada LS, Wang L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Li QZ. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction. Hum Immunol. 2021 Jan; 82 (1):25-35 Epub 2020 Oct 28
    View PubMed
  34. Mahan LD, Kanade R, Mohanka MR, Bollineni S, Joerns J, Kaza V, Torres F, La Hoz RM, Banga A. Characteristics and outcomes among patients with community-acquired respiratory virus infections during the first year after lung transplantation. Clin Transplant. 2021 Jan; 35 (1):e14140 Epub 2020 Nov 20
    View PubMed
  35. Mohanka MR, Kanade R, Garcia H, Mahan L, Bollineni S, Mullins J, Joerns J, Kaza V, Torres F, Zhang S, Banga A. Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes. Transplantation. 2020 Aug; 104 (8):1712-1719
    View PubMed
  36. Mohanka MR, Kanade R, Garcia H, Mahan L, Bollineni S, Mullins J, Joerns J, Kaza V, Torres F, Zhang S, Banga A. Significance of Best Spirometry in the First Year After Bilateral Lung Transplantation: Association With 3-Year Outcomes. Transplantation. 2020 Aug; 104 (8):1712-1719
    View PubMed
  37. Kaza V, Zhu C, Feng L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Terada LS, Li QZ. Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation. Transpl Immunol. 2020 Apr; 59:101271 Epub 2020 Jan 30
    View PubMed
  38. Kaza V, Zhu C, Feng L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Terada LS, Li QZ. Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation. Transpl Immunol. 2020 Apr; 59:101271 Epub 2020 Jan 30
    View PubMed
  39. Woll F, Mohanka M, Bollineni S, Joerns J, Kaza V, Torres F, Tanriover B, Banga A. Characteristics and Outcomes of Lung Transplant Candidates With Preexisting Renal Dysfunction. Transplant Proc. 2020 Jan-Feb; 52 (1):302-308 Epub 2020 Jan 08
    View PubMed
  40. Woll F, Mohanka M, Bollineni S, Joerns J, Kaza V, Torres F, Tanriover B, Banga A. Characteristics and Outcomes of Lung Transplant Candidates With Preexisting Renal Dysfunction. Transplant Proc. 2020 Jan-Feb; 52 (1):302-308 Epub 2020 Jan 08
    View PubMed
  41. Kalinowski A, Galen BT, Ueki IF, Sun Y, Mulenos A, Osafo-Addo A, Clark B, Joerns J, Liu W, Nadel JA, Dela Cruz CS, Koff JL. Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol. 2018 May; 11 (3):958-967 Epub 2018 Feb 07
    View PubMed
  42. Kalinowski A, Galen BT, Ueki IF, Sun Y, Mulenos A, Osafo-Addo A, Clark B, Joerns J, Liu W, Nadel JA, Dela Cruz CS, Koff JL. Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol. 2018 May; 11 (3):958-967 Epub 2018 Feb 07
    View PubMed